Vaccination against coronavirus disease 2019 in patients with pulmonary hypertension: a national prospective cohort study
Description
CONCLUSIONS: COVID-19 vaccination did not significantly augment the PH-related major adverse events for patients with WHO groups 1 and 4 PH, although there were some tolerable side effects. A large-scale randomized controlled trial is warranted to
